Gilead (GILD) Lags Other Biotechs Following HCV Data From Regulus (RGLS)

Go back to Gilead (GILD) Lags Other Biotechs Following HCV Data From Regulus (RGLS)
AbbVie (NYSE: ABBV) Delayed: 248.00 -1.91 (0.76%)
Previous Close $249.91    52 Week High $68.12 
Open $251.01    52 Week Low $50.71 
Day High $251.66    P/E 53.80 
Day Low $245.05    EPS $4.61 
Volume 3,086,768       

Gilead Sciences (NASDAQ: GILD) Delayed: 130.07 -4.77 (3.54%)
Previous Close $134.84    52 Week High $108.63 
Open $134.02    52 Week Low $71.39 
Day High $134.97    P/E 71.86 
Day Low $129.27    EPS $1.81 
Volume 3,403,812       

Merck & Co. (NYSE: MRK) Delayed: 123.61 -1.46 (1.17%)
Previous Close $125.07    52 Week High $65.46 
Open $125.12    52 Week Low $47.97 
Day High $125.56    P/E 84.09 
Day Low $122.90    EPS $1.47 
Volume 5,185,438       

REGULUS THERAP (NASDAQ: RGLS) Delayed: 8.16 --0 (-0%)
Previous Close $8.16    52 Week High $10.60 
Open $8.16    52 Week Low $2.13 
Day High $8.16    P/E 0.21 
Day Low $8.16    EPS $38.45 
Volume 233